Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma

by Terufumi Shimoda, Hiroshi Odajima, Arisa Okamasa, Minako Kawase, Masaki Komatsubara, Bhabita Mayer, Steven Yancey, Hector Ortega
Published 2017-07-01

Outcomes following mepolizumab treatment discontinuation: real-world experience from an open-label trial

by Hector Ortega, Catherine Lemiere, Jean-Pierre Llanos, Mark Forshag, Robert Price, Frank Albers, Steven Yancey, Mario Castro
Published 2019-06-01

Response to mepolizumab treatment is sustained across 4-weekly dosing periods

by Ian D. Pavord, Eugene R. Bleecker, Roland Buhl, Pascal Chanez, Elisabeth H. Bel, Peter Howarth, Daniel J. Bratton, Frank C. Albers, Steven Yancey
Published 2020-09-01